Qlucore launches AI-based AML test

AnBogen Therapeutics to present Imofinostat (ABT-301) breakthroughs at AACR 2026

Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer

DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer

Oricell Therapeutics completes USD110m pre-IPO financing

Tempus expands oncology collaboration with Gilead to accelerate AI-driven R&D

Coiled Therapeutics reports enhanced efficacy for AO-252 and accelerates transition to dose expansion

IDEOlogy Health and West Cancer Center partner to advance patient-centred oncology education and care

Gilead to acquire Tubulis to expand ADC oncology capabilities

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal